Dasatinib - Wikipedia

Dasatinib, sold under the brand name Sprycel, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia ...

Dasatinib Monograph for Professionals - Drugs.com

Dasatinib reference guide for safe and effective use from the American Society of Health-System Pharmacists (AHFS DI).

Dasatinib, nilotinib and imatinib for untreated chronic ...

Evidence-based recommendations on dasatinib (Sprycel), nilotinib (Tasigna) and imatinib (Glivec) for untreated chronic myeloid leukaemia in adults

SPRYCEL - Chemotherapy Drugs - Chemocare

SPRYCEL (Dasatinib) signal transduction inhibitor targeted therapy side effects, how it's given, how it works, precautions and self care tips for treatment of leukemia

DRUG NAME: Dasatinib - BC Cancer

85%; 19% as dasatinib terminal half life 5-6 h clearance no information found Sex no clinically significant differences Elderly no clinically significant ...

SPRYCEL® (dasatinib) | SPRYCEL.com

INDICATIONS AND USAGE. SPRYCEL ® (dasatinib) is a prescription medicine used to treat: adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic ...

Nilotinib - Wikipedia

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of ...

Sprycel 20mg Film Coated Tablets - Summary of Product ...

Sprycel 20mg Film Coated Tablets - Summary of Product Characteristics (SmPC) by Bristol-Myers Squibb Pharmaceuticals limited

Drug - SPRYCEL® [tab] 50mg - 50 Tablets Tablet (Dasatinib ...

SPRYCEL® [tab] 50mg - 50 Tablets Tablet (Dasatinib) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects ...

SPRYCEL (dasatinib) tablets label

(dasatinib) is indicated for the treatment of adults with • newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia